Arthritis Immune Cells Differ From COVID-19
Adults with rheumatoid arthritis may find this comparison useful, as many neutrophil genes behave differently than in COVID-19.
Updated on Nov. 4, 2026 in Arthritis

Researchers compared the immune-cell activity of neutrophils in people with rheumatoid arthritis and in people with COVID-19, using publicly available gene-activity data. Their analysis found that the two conditions share few patterns and that many genes move in opposite directions.
Why it matters
Neutrophils are the most common white blood cells and a key part of the body's first response to inflammation, so differences in how they behave help explain why conditions like rheumatoid arthritis and viral infections affect the body differently. Understanding where these immune responses diverge may help clinicians and researchers think more precisely about inflammatory disease, though this is an analysis of existing data rather than a clinical finding.
This reanalysis of existing neutrophil gene-expression datasets compared rheumatoid arthritis and COVID-19 samples, finding 11,355 differentially expressed genes in rheumatoid arthritis versus 420 in COVID-19. The study is a secondary analysis of public data, not a new clinical trial, and its conclusions about shared versus distinct immune signatures remain preliminary.
The details
Neutrophils were examined by measuring which genes are switched on or off in these cells, using differential expression analysis (DESeq2) and pathway enrichment tools (fgsea and topGO). In rheumatoid arthritis, interferon alpha and interferon gamma response pathways led the list of enriched gene sets, pointing to a strong interferon-driven signature in these immune cells. In COVID-19, no pathway reached statistical significance, and many of the rheumatoid arthritis genes instead changed in the opposite direction, including CAMK1G, SIGLEC1, OAS1 and OAS3.
Health Landscape
Interferon signaling has been studied as a feature of several autoimmune and viral conditions, and this comparison places rheumatoid arthritis and COVID-19 side by side at the level of neutrophil gene activity. The work adds to a growing body of research that uses shared public datasets to test whether inflammatory diseases with different causes share or diverge in their immune signatures.
If you live with rheumatoid arthritis, this research is a reminder that the immune system's inflammatory pathways differ from those seen in viral infections, which is worth keeping in mind when discussing symptoms with your doctor. Because this is laboratory-level data analysis and not a change in care, it does not alter current treatment, so any questions about your own management are best raised with your physician.
The takeaway
The big insight is that rheumatoid arthritis and COVID-19 engage neutrophils in largely different ways, with many genes moving in opposite directions. If you have an inflammatory condition, keep up regular checkups and ask your doctor whether any emerging immune research is relevant to your care.
Further reading
For broader background on the joint condition at the center of this comparison, explore our Arthritis coverage.
Source note: This article includes information reported by Biorxiv.


